HSB 888
Alternative Names: HSB-888Latest Information Update: 15 Jan 2024
At a glance
- Originator Hillstream BioPharma
- Developer Tharimmune
- Class Anthracyclines; Antineoplastics; Small molecules
- Mechanism of Action Cell death stimulants; DNA intercalators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Osteosarcoma; Solid tumours